Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis

Author:

Amani Behnam¹^ORCID,Amani Bahman²^ORCID,Zareei Sara³^ORCID,Zareei Mahsa⁴^ORCID

Affiliation:

1. Department of Health Management and Economics, School of Public Health Tehran University of Medical Sciences Tehran Iran

2. Health Management and Economics Research Center, Health Management Research Institute Iran University of Medical Sciences Tehran Iran

3. Department of Cell & Molecular Biology, Faculty of Biological Sciences Kharazmi University Tehran Iran

4. Department of Health Services Management, School of Health Management and Information Sciences Iran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

Reference59 articles.

4. Interferon beta‐1a as a candidate for COVID‐19 treatment; an open‐label single‐arm clinical trial;Payandemehr P;Front Emerg Med,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献